BacterioScan Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Bankr. Admin/Reorg
BacterioScan General Information
Description
Manufacturer of medical devices intended to transform urinary tract infection diagnosis. The company's precision instrumentation rapidly detects and measures microorganism growth in liquid specimens and determines if it is resistant to a range of antibiotics, enabling clinicians to improve the quality of antibiotic therapy and reduce excess or inappropriate use of antibiotics and deter antibiotic resistance.
Contact Information
Website
www.bacterioscan.comCorporate Office
- 2210 Welsch Industrial Court
- Saint Louis, MO 63146
- United States
Corporate Office
- 2210 Welsch Industrial Court
- Saint Louis, MO 63146
- United States
BacterioScan Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Bankruptcy: Admin/Reorg | 15-Nov-2021 | Completed | Bankruptcy: Admin/Reorg | |||
| 7. Debt - General | Completed | Generating Revenue | ||||
| 6. Debt - PPP | 29-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 13-Feb-2018 | Completed | Generating Revenue | |||
| 4. Grant | 03-Jan-2018 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 07-Aug-2015 | $1.4M | $7.9M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 01-Apr-2015 | $6.5M | $6.5M | Completed | Generating Revenue |
BacterioScan Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
BacterioScan Patents
BacterioScan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11099121-B2 | Cuvette device for determining antibacterial susceptibility | Active | 05-Feb-2019 | ||
| US-20200249148-A1 | Cuvette device for determining antibacterial susceptibility | Active | 05-Feb-2019 | ||
| US-20200156057-A1 | Systems and methods using bacteriophage-mediated lysis for detection and identification of microorganisms in a fluid sample | Inactive | 21-Nov-2018 | ||
| US-20260102765-A1 | Systems and methods using bacteriophage-mediated lysis for detection and identification of microorganisms in a fluid sample | Pending | 21-Nov-2018 | ||
| WO-2020106887-A2 | Systems and methods using bacteriophage-mediated lysis for detection and identification of microorganisms in a fluid sample | Inactive | 21-Nov-2018 | C12Q1/04 |
BacterioScan Signals
BacterioScan FAQs
-
When was BacterioScan founded?
BacterioScan was founded in 2005.
-
Where is BacterioScan headquartered?
BacterioScan is headquartered in Saint Louis, MO.
-
What is the size of BacterioScan?
BacterioScan has 16 total employees.
-
What industry is BacterioScan in?
BacterioScan’s primary industry is Diagnostic Equipment.
-
Is BacterioScan a private or public company?
BacterioScan is a Private company.
-
What is BacterioScan’s current revenue?
The current revenue for BacterioScan is .
-
How much funding has BacterioScan raised over time?
BacterioScan has raised $18.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process